The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Mice, Inbred NOD

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Mice, Inbred NOD


Psychiatry related information on Mice, Inbred NOD


High impact information on Mice, Inbred NOD


Chemical compound and disease context of Mice, Inbred NOD


Biological context of Mice, Inbred NOD


Anatomical context of Mice, Inbred NOD


Associations of Mice, Inbred NOD with chemical compounds


Gene context of Mice, Inbred NOD


Analytical, diagnostic and therapeutic context of Mice, Inbred NOD


  1. The role of Fas in autoimmune diabetes. Chervonsky, A.V., Wang, Y., Wong, F.S., Visintin, I., Flavell, R.A., Janeway, C.A., Matis, L.A. Cell (1997) [Pubmed]
  2. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Tian, J., Clare-Salzler, M., Herschenfeld, A., Middleton, B., Newman, D., Mueller, R., Arita, S., Evans, C., Atkinson, M.A., Mullen, Y., Sarvetnick, N., Tobin, A.J., Lehmann, P.V., Kaufman, D.L. Nat. Med. (1996) [Pubmed]
  3. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Shizuru, J.A., Taylor-Edwards, C., Banks, B.A., Gregory, A.K., Fathman, C.G. Science (1988) [Pubmed]
  4. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. Salomon, B., Rhee, L., Bour-Jordan, H., Hsin, H., Montag, A., Soliven, B., Arcella, J., Girvin, A.M., Padilla, J., Miller, S.D., Bluestone, J.A. J. Exp. Med. (2001) [Pubmed]
  5. Viruses as therapeutic agents. II. Viral reassortants map prevention of insulin-dependent diabetes mellitus to the small RNA of lymphocytic choriomeningitis virus. Oldstone, M.B., Ahmed, R., Salvato, M. J. Exp. Med. (1990) [Pubmed]
  6. Tolerance mechanisms in murine autoimmune diabetes induced by anti-ICAM-1/LFA-1 mAb and anti-CD8 mAb. Chowdhury, S.A., Nagata, M., Yamada, K., Nakayama, M., Chakrabarty, S., Jin, Z., Kotani, R., Yokono, K. The Kobe journal of medical sciences. (2002) [Pubmed]
  7. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Han, B., Serra, P., Amrani, A., Yamanouchi, J., Marée, A.F., Edelstein-Keshet, L., Santamaria, P. Nat. Med. (2005) [Pubmed]
  8. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Sharif, S., Arreaza, G.A., Zucker, P., Mi, Q.S., Sondhi, J., Naidenko, O.V., Kronenberg, M., Koezuka, Y., Delovitch, T.L., Gombert, J.M., Leite-De-Moraes, M., Gouarin, C., Zhu, R., Hameg, A., Nakayama, T., Taniguchi, M., Lepault, F., Lehuen, A., Bach, J.F., Herbelin, A. Nat. Med. (2001) [Pubmed]
  9. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Hong, S., Wilson, M.T., Serizawa, I., Wu, L., Singh, N., Naidenko, O.V., Miura, T., Haba, T., Scherer, D.C., Wei, J., Kronenberg, M., Koezuka, Y., Van Kaer, L. Nat. Med. (2001) [Pubmed]
  10. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Ramiya, V.K., Maraist, M., Arfors, K.E., Schatz, D.A., Peck, A.B., Cornelius, J.G. Nat. Med. (2000) [Pubmed]
  11. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Tisch, R., Yang, X.D., Singer, S.M., Liblau, R.S., Fugger, L., McDevitt, H.O. Nature (1993) [Pubmed]
  12. Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice. Hunger, R.E., Carnaud, C., Vogt, I., Mueller, C. J. Clin. Invest. (1998) [Pubmed]
  13. Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue. Yasumizu, R., Sugiura, K., Iwai, H., Inaba, M., Makino, S., Ida, T., Imura, H., Hamashima, Y., Good, R.A., Ikehara, S. Proc. Natl. Acad. Sci. U.S.A. (1987) [Pubmed]
  14. Tolerance to IDDM induced by CD4 antibodies in nonobese diabetic mice is reversed by cyclophosphamide. Parish, N.M., Hutchings, P.R., Waldmann, H., Cooke, A. Diabetes (1993) [Pubmed]
  15. The pharmacokinetics of nicotinamide in humans and rodents. Petley, A., Macklin, B., Renwick, A.G., Wilkin, T.J. Diabetes (1995) [Pubmed]
  16. Prevention of autoimmune diabetes by linomide in nonobese diabetic (NOD) mice is associated with up-regulation of the TCR-mediated activation of p21(ras). Rapoport, M.J., Weiss, L., Mor, A., Bistritzer, T., Ramot, Y., Slavin, S. J. Immunol. (1996) [Pubmed]
  17. Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice. Miyazaki, T., Uno, M., Uehira, M., Kikutani, H., Kishimoto, T., Kimoto, M., Nishimoto, H., Miyazaki, J., Yamamura, K. Nature (1990) [Pubmed]
  18. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Lund, T., O'Reilly, L., Hutchings, P., Kanagawa, O., Simpson, E., Gravely, R., Chandler, P., Dyson, J., Picard, J.K., Edwards, A. Nature (1990) [Pubmed]
  19. Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Hugues, S., Mougneau, E., Ferlin, W., Jeske, D., Hofman, P., Homann, D., Beaudoin, L., Schrike, C., Von Herrath, M., Lehuen, A., Glaichenhaus, N. Immunity (2002) [Pubmed]
  20. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Vijayakrishnan, L., Slavik, J.M., Illés, Z., Greenwald, R.J., Rainbow, D., Greve, B., Peterson, L.B., Hafler, D.A., Freeman, G.J., Sharpe, A.H., Wicker, L.S., Kuchroo, V.K. Immunity (2004) [Pubmed]
  21. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Lee, K.H., Wucherpfennig, K.W., Wiley, D.C. Nat. Immunol. (2001) [Pubmed]
  22. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Kaufman, D.L., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G.S., Robinson, P., Atkinson, M.A., Sercarz, E.E., Tobin, A.J., Lehmann, P.V. Nature (1993) [Pubmed]
  23. Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes. Lehuen, A., Lantz, O., Beaudoin, L., Laloux, V., Carnaud, C., Bendelac, A., Bach, J.F., Monteiro, R.C. J. Exp. Med. (1998) [Pubmed]
  24. In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. Healey, D., Ozegbe, P., Arden, S., Chandler, P., Hutton, J., Cooke, A. J. Clin. Invest. (1995) [Pubmed]
  25. Prevention of type 1 diabetes by gene therapy. Tian, C., Bagley, J., Cretin, N., Seth, N., Wucherpfennig, K.W., Iacomini, J. J. Clin. Invest. (2004) [Pubmed]
  26. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Corper, A.L., Stratmann, T., Apostolopoulos, V., Scott, C.A., Garcia, K.C., Kang, A.S., Wilson, I.A., Teyton, L. Science (2000) [Pubmed]
  27. Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model. Larger, E., Bécourt, C., Bach, J.F., Boitard, C. J. Exp. Med. (1995) [Pubmed]
  28. Androgen treatment prevents diabetes in nonobese diabetic mice. Fox, H.S. J. Exp. Med. (1992) [Pubmed]
  29. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. Grohmann, U., Fallarino, F., Bianchi, R., Orabona, C., Vacca, C., Fioretti, M.C., Puccetti, P. J. Exp. Med. (2003) [Pubmed]
  30. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. Rothe, H., Jenkins, N.A., Copeland, N.G., Kolb, H. J. Clin. Invest. (1997) [Pubmed]
  31. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Salomon, B., Lenschow, D.J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., Bluestone, J.A. Immunity (2000) [Pubmed]
  32. Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. Wu, Q., Salomon, B., Chen, M., Wang, Y., Hoffman, L.M., Bluestone, J.A., Fu, Y.X. J. Exp. Med. (2001) [Pubmed]
  33. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. Lenschow, D.J., Ho, S.C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K.C., Bluestone, J.A. J. Exp. Med. (1995) [Pubmed]
  34. Aod2, the locus controlling development of atrophy in neonatal thymectomy-induced autoimmune ovarian dysgenesis, co-localizes with Il2, Fgfb, and Idd3. Teuscher, C., Wardell, B.B., Lunceford, J.K., Michael, S.D., Tung, K.S. J. Exp. Med. (1996) [Pubmed]
  35. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. Ansari, M.J., Salama, A.D., Chitnis, T., Smith, R.N., Yagita, H., Akiba, H., Yamazaki, T., Azuma, M., Iwai, H., Khoury, S.J., Auchincloss, H., Sayegh, M.H. J. Exp. Med. (2003) [Pubmed]
  36. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Hutchings, P., Rosen, H., O'Reilly, L., Simpson, E., Gordon, S., Cooke, A. Nature (1990) [Pubmed]
  37. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Sánchez-Fueyo, A., Tian, J., Picarella, D., Domenig, C., Zheng, X.X., Sabatos, C.A., Manlongat, N., Bender, O., Kamradt, T., Kuchroo, V.K., Gutiérrez-Ramos, J.C., Coyle, A.J., Strom, T.B. Nat. Immunol. (2003) [Pubmed]
  38. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1. Moritani, M., Yoshimoto, K., Wong, S.F., Tanaka, C., Yamaoka, T., Sano, T., Komagata, Y., Miyazaki, J., Kikutani, H., Itakura, M. J. Clin. Invest. (1998) [Pubmed]
  39. Primary Sjögren's syndrome and deficiency of ICA69. Winer, S., Astsaturov, I., Cheung, R., Tsui, H., Song, A., Gaedigk, R., Winer, D., Sampson, A., McKerlie, C., Bookman, A., Dosch, H.M. Lancet (2002) [Pubmed]
  40. Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice. Nomikos, I.N., Prowse, S.J., Carotenuto, P., Lafferty, K.J. Diabetes (1986) [Pubmed]
WikiGenes - Universities